期刊文献+

丹参联合厄贝沙坦治疗早期慢性肾功能衰竭疗效观察 被引量:2

Observation of therapeutic effects of Salvia Miltiorrhiza combined with Irbesartan on chronic renal failure in early stage
暂未订购
导出
摘要 目的探讨丹参对早期慢性肾功能衰竭患者的肾保护作用。方法将63例慢性肾功能衰竭患者随机分为2组:对照组予厄贝沙坦治疗,治疗组予丹参联合厄贝沙坦洽疗,疗程均为6个月,观察2组肾功能、血脂改善情况。结果2组患者的肾功能、尿蛋白和血脂均有明显改善,但治疗组明显优于对照组。结论丹参能够有效降低早期慢性肾功能衰竭患者的尿蛋白水平,纠正患者的血脂代谢紊乱,延缓慢性肾功能衰竭的进展。 Objective It is to investigate the beneficial effects of Salvia Miltiorrhiza on renal in patients with early stage chronic renal failure(CRF).Methods 63 patients with CRF were randomly divided into two groups: the control group was given Irbesartan and the treatment group given Salvia Miltiorrhiza in addition to Irbesartan.The therapeutic course of both groups was six months.The improvement of renal function and blood fat in both groups were observed.Results After treatment,renal function,urine protein and blood fat in both groups were observed. Results After treatment, renal function, urine protein and blood fat in both groups were obviously improved, but the improvement in treatment group was more significant than that in control group. Conclusion Salvia Miltiorrhiza can effectively low down the level of urine protein, improve the disorder of blood fat metabolism and inhibit the progress of CRF in patients with early stage CRF.
出处 《现代中西医结合杂志》 CAS 2009年第34期4187-4188,4191,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
基金 南京医科大学科技发展基金重点资助项目(2005NYD2D14)
关键词 丹参 肾功能 蛋白尿 血脂 厄贝沙坦 Salvia Miltiorrhiza renal function proteinuria blood lipids Irbesartan
  • 相关文献

参考文献12

二级参考文献50

  • 1张悦 ,何立群 ,韩志芬 ,庞惠芳 ,曹和欣 ,朱晓梅 .抗纤灵、丹参、大黄等药物血清对系膜细胞分泌FN和Ⅳ型胶原的影响[J].中国病理生理杂志,2005,21(8):1643-1643. 被引量:10
  • 2柳刚,关广聚,亓同钢,傅余芹,李学刚,孙云,吴涛,文蓉珠.丹参对糖尿病大鼠肾脏的保护作用及其机制研究[J].中西医结合学报,2005,3(6):459-462. 被引量:52
  • 3Carmel A, Yaron A. An intramolecularly quenched fluorescent tripeptide as a fluorogenic substrate of angiotensin-I-converting enzyme and of bacterial dipeptidyl carboxypeptidase. Eur J Biochem, 1978, 87(2) :265.
  • 4Cheung H S, Wang F L, Ondetti M A, etal. Binding ofpeptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence. J Biol Chem, 1980, 255:401.
  • 5Duncan A C, Jager A K, Staden J. Screening of Zulu medicinal plants for angiotensin converting enzyme (ACE) inhibitors. J Ethnopharm, 1999, 68: 63.
  • 6Yokozawa T, Lee T W, Chung H Y, et al. Renal responses to magnesium lithospermate B. J Pharm Pharmacol, 1990, 42(10): 712.
  • 7Yokozawa T, Lee T W,Oura H, et al. Effect of magnesium lithospermate B in rats with sodium-induced hypertension and renal failure.Nephron, 1992, 60(4): 460.
  • 8Kamata K, lizuka T, Nagai M, et al. Endothelium-dependent vasodilator effects of the extract from Salviae Miltiorrhizae radix. A study on the identification of lithospermic acid B in the extracts. Gen Pharmacol, 1993, 24(4):977.
  • 9Yokozawa T, Chung H Y, LeeT W,et al. Potentiating effect of converting enzyme inhibitor captopril to the renal responses of magnesium lithospermate B in rats with adenine-induced renal failure. Chem Pharm Bull , 1991, 39(3):732.
  • 10Cushman D W, Cheung H S. Spectrophotometric assay and properties of the angiotensin converting enzyme of rabbit lung. Biochem Pharmcol, 1971, 20: 1637.

共引文献719

同被引文献32

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部